Download Guro Gafvelin's presentation

Email address:

First name:

Last name:

Job title:

Company name:

Country:

I work for

Please specify your industry *

Mobile number:

What is your role?

Subscribe to VaccineNation Newsletter?

Unfortunately the document is not available at this current time, however if you leave your details we'll get it to you as soon as we can.

Please fill in all the information requested. It is very important you enter this information correctly so we can contact you with the document.

Remember my details Information

Remember my details

We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

close »

Guro Gafvelin, Viscogel joined us last year at the World Vaccine Congress Europe to present on ‘Clinical results from a Phase I/IIa trial with the chitosan based adjuvant ViscoGel’

Download this presentation now to find out more about:

ViscoGel® - a viscoelastic hydrogel based on chitosan

Unique advantages of ViscoGel as adjuvant

Model vaccine for Proof-of-concept studies of ViscoGel as adjuvant

Pre-clinical evaluation: ViscoGel enhances the antibody response to Act-HIB

ViscoGel enhances the cellular response and promotes a mixed cytokine profile in response to Act-HIB

…And much more!

Get your copy here!

If you are interested in finding out more about vaccine supply, then join us at the 15th Annual World Vaccine Congress Europe.